Build a Preclinical Strategy That Holds Up When It Matters Most

Start with a complimentary Strategy Call. In 30 minutes, share your program details, stage, and most pressing decisions. BridgeLine will recommend whether to begin with a Strategy Diagnostic, move directly into a core engagement like a Preclinical Roadmap or Diligence Readiness Package, or start with advisory support. Most companies begin with a Diagnostic because it covers the broadest ground and the findings directly scope any follow-on engagement.

The Strategy Diagnostic is a focused 1-2 week assessment available for any of the three pillars: preclinical strategy, target & indication strategy, or investor & partner readiness. BridgeLine identifies the right one on the Strategy Call based on where you need the most clarity. You receive scored assessments across multiple dimensions, gap analysis with specific recommendations, prioritized action items, and deliverables structured for leadership review. Available as an Initial Assessment (starting from discovery) or a Gap Analysis (reviewing an existing strategy against real-world benchmarks).

Yes. Every deliverable is structured for immediate use in board updates, investor conversations, partner discussions, and data rooms. Visual timelines, detailed budget tables, risk assessments with mitigations, competitive positioning, and executive summaries. No translation layer needed between what BridgeLine delivers and what your audience sees.

BridgeLine works with any modality but specializes in gene therapy (AAV, lentiviral, LNP, non-viral), RNA therapeutics (mRNA, siRNA, ASO, miRNA), gene editing (CRISPR/Cas9, base editing, prime editing, RNA editing), and biologics (antibodies, engineered proteins, enzymes).

You can combine Preclinical Roadmap, Diligence Readiness Package, and Target & Indication Evaluation in one coordinated engagement. No separate SKU needed. Many Series A and Series B companies take this approach because it produces a unified strategy across development planning, investor readiness, and portfolio prioritization. Scope and timeline are defined on the Strategy Call based on your priorities and stage.

Most engagements begin within 1-2 weeks of the Strategy Call. Strategy Diagnostics deliver in 1-2 weeks. Core engagements: Target & Indication Evaluation and Diligence Readiness Package deliver in 2-4 weeks; Preclinical Roadmaps deliver in 2-4 weeks. Advisory and fractional support can start within days of finalizing scope. Expedited timelines are available for diagnostics.